Debiopharm invests double digit millions in GenePOC

Debiopharm invests double-digit millions in  GenePOC, specialized in the development of rapid diagnostic tests. GenePOC, which has just received CE marking for its first bacteriological test, will start commercialization in Europe this autumn, and Debiopharm will set up a future production line in Martigny. Click here for the details.